Lord Abbett Health Care Fund (LHCQX) is an MF managed by Independent / Boutique. Its largest position is ELI LILLY & Co (LLY), representing 8.89% of fund assets.
Lord Abbett Health Care Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- LHCQX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
8.89% | $724,315.00 | 775 |
|
-
ASTRAZENECA PLC
|
4.73% | $384,946.37 | 2,029 |
|
-
GILEAD SCIENCES, INC.
|
4.25% | $346,333.48 | 2,647 |
|
-
JOHNSON & JOHNSON
|
3.19% | $259,500.65 | 1,129 |
|
-
NEKTAR THERAPEUTICS
|
3.17% | $258,351.52 | 3,038 |
|
-
Natera, Inc.
|
2.91% | $237,290.16 | 1,151 |
|
-
Tarsus Pharmaceuticals, Inc.
|
2.83% | $230,395.42 | 3,622 |
|
-
Guardant Health, Inc.
|
2.63% | $214,129.72 | 2,459 |
|
-
ARGENX SE
|
2.49% | $203,114.97 | 259 |
|
-
NOVARTIS AG
|
2.46% | $200,402.79 | 1,356 |
|
-
CVS HEALTH Corp
|
2.37% | $193,232.80 | 2,320 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
2.22% | $181,086.50 | 350 |
|
-
INTUITIVE SURGICAL INC
|
2.21% | $179,840.73 | 393 |
|
-
Cogent Biosciences, Inc.
|
2.19% | $178,341.57 | 4,983 |
|
-
GALDERMA GROUP AG
|
2.11% | $171,610.96 | 818 |
|
-
UNITEDHEALTH GROUP INC
|
2.10% | $170,791.28 | 461 |
|
-
Celcuity Inc.
|
2.01% | $163,701.15 | 1,349 |
|
-
BridgeBio Pharma, Inc.
|
1.99% | $161,988.58 | 2,278 |
|
-
Cencora, Inc.
|
1.99% | $161,705.25 | 525 |
|
-
Ascendis Pharma A/S
|
1.97% | $160,107.24 | 698 |
|
-
Abivax S.A.
|
1.87% | $152,124.48 | 1,296 |
|
-
Edwards Lifesciences Corp
|
1.82% | $148,212.50 | 1,775 |
|
-
FIXED INCOME CLEARING CORP
|
1.78% | $144,817.78 | 144,818 |
|
-
Mirum Pharmaceuticals, Inc.
|
1.75% | $142,753.77 | 1,467 |
|
-
UCB SA
|
1.74% | $142,136.05 | 522 |
|
-
FIDELITY INVESTMENTS
|
1.72% | $139,927.50 | 139,928 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
1.70% | $138,285.00 | 1,575 |
|
-
UNITED THERAPEUTICS Corp
|
1.64% | $133,695.90 | 234 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
1.63% | $132,915.18 | 311 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
1.48% | $120,697.92 | 252 |
|
-
Revolution Medicines, Inc.
|
1.35% | $110,107.68 | 764 |
|
-
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
1.27% | $103,701.99 | 2,957 |
|
-
Adaptive Biotechnologies Corp
|
1.17% | $95,442.90 | 6,769 |
|
-
PTC THERAPEUTICS, INC.
|
1.12% | $91,149.06 | 1,401 |
|
-
INSMED Inc
|
1.05% | $85,887.90 | 630 |
|
-
Mineralys Therapeutics, Inc.
|
1.05% | $85,813.00 | 3,220 |
|
-
OTSUKA CORPORATION
|
1.04% | $84,689.07 | 1,162 |
|
-
CG Oncology, Inc.
|
1.00% | $81,623.02 | 1,223 |
|
-
BeOne Medicines Ltd.
|
0.94% | $76,882.08 | 3,387 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.94% | $76,641.12 | 942 |
|
-
GLAUKOS Corp
|
0.93% | $75,570.42 | 526 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
0.87% | $70,687.76 | 962 |
|
-
10x Genomics, Inc.
|
0.87% | $70,560.00 | 3,200 |
|
-
Heartflow, Inc.
|
0.86% | $70,233.60 | 2,360 |
|
-
Encompass Health Corp
|
0.83% | $67,700.00 | 677 |
|
-
GeneDx Holdings Corp.
|
0.81% | $65,782.94 | 1,046 |
|
-
TransMedics Group, Inc.
|
0.80% | $65,513.50 | 650 |
|
-
DBV Technologies S.A.
|
0.77% | $62,433.00 | 2,973 |
|
-
STRYKER CORP
|
0.72% | $58,614.18 | 186 |
|
-
Protagonist Therapeutics, Inc
|
0.70% | $57,402.60 | 580 |
Advertisement (320x50)